Babies Born To Women Who Receive Antithyroid Medications For Graves Disease During First Trimester May Have An Increased Risk For Congenital Malformations,

“The risk of congenital malformations may be substantially higher for babies exposed to antithyroid medications in utero,” researchers found. Expectant mothers “with Graves’ disease medicated during the first trimester showed a higher prevalence of babies born with either overall or organ-specific congenital malformations versus mothers not on the medication,” the study revealed. The findings of the 12,891-case study were published online in the Annals of Internal Medicine. Medscape (1/22, Brown) also covers the study. https://www.medpagetoday.com/endocrinology/thyroid/70667